显影剂市场规模、份额及成长分析（按类型、形式、方式、给药途径、适应症、应用、最终用户和地区）－2025 年至 2032 年产业预测

2023 年显影剂市场规模价值 69 亿美元，预计将从 2024 年的 74.6 亿美元成长到 2032 年的 139.1 亿美元，预测期间（2025-2032 年）的复合年增长率为 8.1%。

目前，显影剂市场受到慢性病盛行率上升、影像技术进步以及诊断影像程序增加的影响。然而，安全性问题（尤其是过敏反应）以及显影剂的高成本阻碍了其发展，并可能限制其在发展中地区的应用。儘管面临这些挑战，但在显影剂加强以及新兴市场扩张的推动下，市场预计将稳定成长。这些趋势为相关人员提供了利用进步、满足不断增长的需求、同时解决安全性和可负担性问题的机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术分析

显影剂市场规模（按类型）

• 市场概览
• 碘化显影剂
• 钆基显影剂
• 微气泡显影剂
• 钡基显影剂

显影剂市场规模（按类型）

• 市场概览
• 液体
• 粉末
• 其他格式

对比显影剂市场规模（按方式）

• 市场概览
• X射线
• 电脑断层扫描（CT）
• 磁振造影（MRI）
• 超音波

按给药途径分類的显影剂市场规模

• 市场概览
• 血管内途径
• 口服途径
• 直肠途径
• 其他给药途径

显影剂市场规模（依适应症划分）

• 市场概览
• 心血管疾病
• 癌症
• 胃肠道疾病
• 肌肉骨骼疾病
• 神经系统疾病
• 肾臟疾病

显影剂市场规模（按应用）

• 市场概览
• 放射学
• 介入放射学
• 介入性心臟病学

显影剂市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Bayer AG（Germany）
• GE Healthcare（USA）
• Bracco Imaging SpA（Italy）
• Guerbet（France）
• Lantheus Holdings, Inc.（USA）
• Merck KGaA（Germany）
• FUJIFILM Corporation（Japan）
• Taejoon Pharm Co., Ltd.（South Korea）
• Beijing Beilu Pharmaceutical Co., Ltd.（China）
• Nano Therapeutics Pvt. Ltd.（India）
• CMC Contrast AB（Sweden）
• Imax Diagnostic Imaging（Canada）
• Trivitron Healthcare（India）
• Fresenius Kabi（Germany）
• Sanochemia Pharmazeutika AG（Austria）
• JB Chemicals & Pharmaceuticals Ltd.（India）
• Jodas Expoim Pvt. Ltd.（India）
• Livealth Biopharma（China）
• Spago Nanomedical AB（Sweden）
• Subhra Pharma Pvt. Ltd.（India）

结论和建议

Contrast Media Market size was valued at USD 6.9 billion in 2023 and is poised to grow from USD 7.46 billion in 2024 to USD 13.91 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The contrast media market is currently influenced by a rising prevalence of chronic diseases, advances in imaging technologies, and an increase in diagnostic imaging procedures. However, growth is hindered by safety concerns, particularly regarding allergic reactions, and the high costs associated with contrast agents, which can limit adoption in developing regions. Despite these challenges, the market is expected to experience steady growth driven by innovations in contrast agent development, enhanced technological integration, and expanding markets. These trends present opportunities for stakeholders to capitalize on advancements and cater to growing demand while addressing safety and affordability issues.

Top-down and bottom-up approaches were used to estimate and validate the size of the Contrast Media market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Contrast Media Market Segments Analysis

Global Contrast Media Market is segmented by Type, Form, Modality, Route of Administration, Indication, Application and region. Based on Type, the market is segmented into Iodinated contrast media, Gadolinium-based contrast media, Microbubble contrast media and Barium-based contrast media. Based on Form, the market is segmented into Liquid, Powder and Other forms. Based on Modality, the market is segmented into X-ray, Computed tomography (CT), Magnetic resonance imaging (MRI) and Ultrasound. Based on Route of Administration, the market is segmented into Intravascular route, Oral route, Rectal route and Other routes of administration. Based on Indication, the market is segmented into Cardiovascular disease, Cancer, Gastrointestinal disorders, Musculoskeletal disorders, Neurological disorders and Nephrological disorders. Based on Application, the market is segmented into Radiology, Interventional radiology, Interventional cardiology. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Contrast Media Market

The Contrast Media market is primarily driven by an increasing awareness among patients about the critical role of diagnostic imaging in managing and detecting diseases, leading to a heightened demand for contrast agents. Additionally, the advocacy from healthcare professionals significantly contributes to market growth, as medical practitioners are increasingly acknowledging the value and benefits of contrast-enhanced imaging in achieving accurate diagnoses and outcomes. This recognition has translated into a surge in the number of prescriptions for these agents, further fuelling the expansion of the Contrast Media market as both patients and providers seek to enhance diagnostic effectiveness.

Restraints in the Contrast Media Market

The growth of the Contrast Media market is significantly hindered in many developing regions due to a limited number of healthcare professionals and inadequate access to advanced technologies and facilities. Furthermore, the lack of awareness about the benefits and applications of contrast media can impede market expansion. Additionally, insufficient training for medical practitioners regarding the use of contrast agents and their associated imaging techniques further restricts adoption. These factors collectively contribute to a challenging environment for the growth of the contrast media market, as they prevent effective utilization and understanding of these critical imaging tools within the healthcare sector.

Market Trends of the Contrast Media Market

The Contrast Media market is witnessing a significant trend towards improved safety profiles, driven by advancements in gadolinium-based contrast agents. Research focusing on minimizing nephrogenic systemic fibrosis (NSF) risks has led to the development of novel agents that emphasize reduced gadolinium retention. This shift is pushing healthcare providers to favor agents with enhanced safety features, which are particularly beneficial for patients with compromised renal function. Additionally, the adoption of non-ionic low osmolar contrast agents in computed tomography is gaining traction, as they effectively minimize side effects. This evolving landscape highlights a growing preference for safer, more effective contrast media solutions among healthcare professionals.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Analysis

Global Contrast Media Market Size by Type & CAGR (2025-2032)

• Market Overview
• Iodinated contrast media
• Gadolinium-based contrast media
• Microbubble contrast media
• Barium-based contrast media

Global Contrast Media Market Size by Form & CAGR (2025-2032)

• Market Overview
• Liquid
• Powder
• Other forms

Global Contrast Media Market Size by Modality & CAGR (2025-2032)

• Market Overview
• X-ray
• Computed tomography (CT)
• Magnetic resonance imaging (MRI)
• Ultrasound

Global Contrast Media Market Size by Route of Administration & CAGR (2025-2032)

• Market Overview
• Intravascular route
• Oral route
• Rectal route
• Other routes of administration

Global Contrast Media Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Cardiovascular disease
• Cancer
• Gastrointestinal disorders
• Musculoskeletal disorders
• Neurological disorders
• Nephrological disorders

Global Contrast Media Market Size by Application & CAGR (2025-2032)

• Market Overview
• Radiology
• Interventional radiology
• Interventional cardiology

Global Contrast Media Market Size & CAGR (2025-2032)

• North America (Type, Form, Modality, Route of Administration, Indication, Application)
  • US
  • Canada
• Europe (Type, Form, Modality, Route of Administration, Indication, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Form, Modality, Route of Administration, Indication, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Form, Modality, Route of Administration, Indication, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Form, Modality, Route of Administration, Indication, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guerbet (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Taejoon Pharm Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beijing Beilu Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nano Therapeutics Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMC Contrast AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imax Diagnostic Imaging (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trivitron Healthcare (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanochemia Pharmazeutika AG (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J.B. Chemicals & Pharmaceuticals Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jodas Expoim Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Livealth Biopharma (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spago Nanomedical AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Subhra Pharma Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations